How to Get Jatenzo in Nebraska

What Is Jatenzo and Why Does Access Matter in Nebraska?

Jatenzo is the brand name for oral testosterone undecanoate, the first FDA-approved oral testosterone replacement therapy for adult males with hypogonadism. The FDA granted approval in March 2019 based on data showing that 87% of patients achieved testosterone levels within the normal range (300 to 1 to 100 ng/dL) at the recommended maintenance dose of 237 mg twice daily [1]. That approval changed the treatment field for men who prefer swallowing a capsule over injections or topical gels.

Nebraska presents a specific set of access considerations. The state has no in-state Jatenzo specialty hub, and Nebraska Medicaid does not reimburse for the branded product. Rural patients in counties west of Grand Island may live 100+ miles from the nearest endocrinologist. Telehealth fills part of that gap. Nebraska law permits telehealth prescribing of Schedule III controlled substances (which includes testosterone) after an appropriate provider-patient relationship is established [2]. This means a patient in Scottsbluff can receive a valid Jatenzo prescription from a licensed telehealth provider without driving to Omaha or Lincoln.

The Swerdloff et al. Pharmacokinetic study (2020) confirmed that oral testosterone undecanoate, taken with a meal containing at least 15 g of fat, achieves steady-state testosterone concentrations comparable to eugonadal ranges within 7 days of initiation [3]. That predictable absorption profile makes it well suited for remote management through telehealth follow-up.

Step-by-Step: Getting a Jatenzo Prescription in Nebraska

The prescription process follows a predictable sequence. Start with lab work, then a clinical evaluation, then the prescription itself.

Step 1: Confirm hypogonadism with labs. You need two separate morning fasting total testosterone measurements below 300 ng/dL, drawn before 10:00 AM. Most insurers and the Endocrine Society's 2018 Clinical Practice Guideline require two low readings on different days [4]. A complete blood count (CBC), comprehensive metabolic panel, lipid panel, and PSA (for men aged 40 and older) round out the baseline workup. Free testosterone and SHBG help if the total testosterone result falls in a borderline range (250 to 350 ng/dL).

Step 2: Clinical evaluation. A provider (MD, DO, NP, or PA licensed in Nebraska) reviews your labs and symptoms. Common symptoms include fatigue, reduced libido, erectile dysfunction, depressed mood, and loss of lean mass. The evaluation can happen in person or via a HIPAA-compliant telehealth visit. Nebraska does not require an in-person visit before prescribing a Schedule III controlled substance, provided the telehealth encounter meets standard-of-care documentation requirements [2].

Step 3: Prescription and prior authorization. If the provider determines Jatenzo is appropriate, they submit an electronic prescription to a pharmacy that stocks oral testosterone undecanoate. Most commercial insurers require prior authorization (PA). The PA process typically takes 3 to 7 business days. We cover the PA requirements in detail below.

Telehealth Options for Jatenzo in Nebraska

Telehealth is the fastest route for most Nebraska residents. Three factors make it practical.

Nebraska enacted LB 400 (2021), which extended pandemic-era telehealth flexibility and allowed continued prescribing of controlled substances via audio-video encounters [2]. A provider must hold an active Nebraska medical license or a multistate compact license that includes Nebraska. The provider must also register with the DEA and hold a Nebraska Controlled Substances Registration.

Platforms like HealthRX connect Nebraska patients with licensed providers who specialize in hormone therapy. A typical telehealth pathway looks like this: order labs at a local Quest or Labcorp draw site (Omaha, Lincoln, Grand Island, and Kearney all have locations), complete a video consultation within 48 hours of receiving results, and receive a prescription routed to a pharmacy that carries Jatenzo or a compounded oral testosterone undecanoate formulation.

One practical advantage: telehealth eliminates the 2- to 6-week wait for an in-person endocrinology appointment. In rural Nebraska counties, endocrinologist availability averages 0.7 per 100,000 residents, compared to 2.1 per 100 to 000 in Omaha's Douglas County [5]. Telehealth closes that gap without requiring a 200-mile drive.

Who Can Prescribe Jatenzo in Nebraska: MD, NP, and PA Scope

Nebraska follows a tiered prescribing model for Schedule III controlled substances.

MDs and DOs have full independent prescribing authority for Jatenzo. Board certification in endocrinology or urology is not required, though many insurers look favorably on specialist prescriptions during prior authorization review.

Nurse Practitioners (NPs) gained full practice authority in Nebraska under LB 107 (2015) after completing a transition-to-practice period of 2 to 000 hours under a collaborative agreement. After that threshold, NPs can independently prescribe Schedule III substances including testosterone [6]. An NP who has not yet completed the transition period must prescribe under a signed integrated practice agreement with a physician.

Physician Assistants (PAs) prescribe under a practice agreement with a supervising physician. The agreement must explicitly authorize Schedule III prescribing. PAs can prescribe Jatenzo, but only within the scope defined by their supervising physician's practice.

All three provider types must hold individual DEA registrations and Nebraska Controlled Substances Registration to write testosterone prescriptions.

Prior Authorization: What Nebraska Insurers Require

Most commercial insurers in Nebraska (Blue Cross Blue Shield of Nebraska, Medica, UnitedHealthcare, Aetna) require prior authorization for brand-name Jatenzo. The standard documentation package includes:

1. Two morning total testosterone levels below 300 ng/dL, drawn on separate days
2. Documentation of hypogonadism symptoms (at least two from the AUA/Endocrine Society symptom criteria)
3. Confirmation that the patient does not have breast cancer, polycythemia (hematocrit above 54%), untreated severe sleep apnea, or uncontrolled heart failure
4. For patients over 40: a PSA result and documentation that prostate cancer screening was discussed
5. A rationale for choosing oral testosterone undecanoate over injectable or topical alternatives (most payers require a step therapy fail or documented contraindication)

The step therapy requirement deserves attention. Many insurers require a trial of generic injectable testosterone cypionate or a topical gel before approving Jatenzo. Common accepted reasons for bypassing step therapy include needle phobia with documented clinical basis, occupational exposure risk for topical transfer (e.g., childcare workers, partners of pregnant women), or a history of injection-site reactions.

Nebraska Medicaid does not cover Jatenzo. Medicaid-eligible patients may access testosterone cypionate injections as a covered alternative, or explore compounded oral testosterone undecanoate through a 503A pharmacy at a lower out-of-pocket cost.

PA turnaround averages 3 to 7 business days for commercial plans. Peer-to-peer review requests (where the insurer asks to speak with the prescribing provider) occur in roughly 15% of first-time PA submissions and add 2 to 5 additional business days [7].

Pharmacy Access and 503A Compounding in Nebraska

Nebraska patients have three pharmacy pathways for oral testosterone undecanoate.

Retail specialty pharmacies. Brand-name Jatenzo is stocked by major specialty pharmacies including CVS Specialty, Accredo, and OptumRx mail-order. Retail cash price for Jatenzo averages $550 to $700 per month without insurance. With commercial coverage and a completed PA, copays range from $30 to $150 per month depending on the plan's specialty tier.

503A compounding pharmacies. Nebraska licenses 503A compounding pharmacies under the Nebraska Department of Health and Human Services, Licensure Unit. These pharmacies can compound oral testosterone undecanoate capsules from bulk pharmaceutical-grade powder pursuant to a patient-specific prescription [8]. Compounded oral testosterone undecanoate typically costs $90 to $180 per month, a significant reduction versus brand-name Jatenzo. Nebraska-based 503A pharmacies can fill prescriptions for Nebraska residents, and out-of-state 503A pharmacies licensed to ship into Nebraska may also do so.

A key distinction: 503A compounded products are not FDA-approved and are not AB-rated substitutes for Jatenzo. The prescriber must write the prescription specifically for compounded oral testosterone undecanoate if the patient wants the compounded version. A pharmacist cannot automatically substitute.

503B outsourcing facilities. These are FDA-registered facilities that produce larger batches without patient-specific prescriptions. Some telehealth TRT platforms partner with 503B facilities to supply oral testosterone undecanoate capsules. These products must comply with current good manufacturing practice (cGMP) standards.

Labs and Monitoring After Starting Jatenzo

Initial labs happen before the prescription. Ongoing monitoring follows a set schedule recommended by the Endocrine Society guideline [4] and the AUA guideline on testosterone deficiency [9].

At baseline: total testosterone (two draws), free testosterone, CBC, comprehensive metabolic panel, lipid panel, PSA (age 40+), and LH/FSH if primary vs. Secondary hypogonadism distinction matters for treatment planning.

At 3 months: total testosterone trough (drawn in the morning before the morning dose), CBC (check hematocrit), and liver function tests. The Jatenzo FDA label recommends checking testosterone levels 6 hours after the morning dose during the first month, then adjusting dose to maintain levels between 300 and 1 to 100 ng/dL [1].

At 6 and 12 months: repeat CBC, lipid panel, PSA, and testosterone level. Hematocrit above 54% requires dose reduction, temporary discontinuation, or therapeutic phlebotomy. In the key Jatenzo trial, hematocrit elevation above 54% occurred in 3.5% of patients, compared to 0.8% on placebo [3].

Annually thereafter: testosterone, CBC, lipid panel, PSA. Bone density testing (DEXA) may be considered for men who had severe hypogonadism (total testosterone below 150 ng/dL) at baseline, per the Endocrine Society recommendation [4].

Telehealth providers can order all of these labs at Quest Diagnostics or Labcorp locations throughout Nebraska. Lincoln has 6 draw sites, Omaha has 14, and smaller cities like Grand Island, Kearney, North Platte, and Scottsbluff each have at least one.

Cost Breakdown: Brand vs. Compounded in Nebraska

Price transparency helps patients make informed decisions. Here is what Nebraska patients typically pay.

| Option | Monthly cost | Notes | |---|---|---| | Brand Jatenzo (cash pay) | $550 to $700 | Manufacturer copay card may reduce to $75/month for commercially insured patients | | Brand Jatenzo (with PA-approved insurance) | $30 to $150 copay | Depends on specialty tier placement | | Compounded oral TU (503A, NE pharmacy) | $90 to $180 | Patient-specific Rx required | | Compounded oral TU (503B, mail-order) | $100 to $200 | cGMP facility, some telehealth platforms bundle this | | Generic injectable testosterone cypionate | $30 to $50 | Covered by most plans including Medicaid |

Tolmar offers a patient savings program for commercially insured patients that can reduce out-of-pocket costs to as low as $75 per month. The savings card does not apply to government-funded insurance (Medicaid, Medicare, Tricare, VA). Eligibility details are on the Jatenzo manufacturer website.

Transferring a Jatenzo Prescription to Nebraska

If you are moving to Nebraska from another state, your existing Jatenzo prescription can be transferred. The process requires:

1. Your current pharmacy contacts the receiving Nebraska pharmacy to initiate the transfer
2. The receiving pharmacy must verify that the prescriber's DEA registration covers the transfer (an out-of-state prescriber can write a one-time transfer, but ongoing refills require a Nebraska-licensed provider)
3. Nebraska law permits transfer of Schedule III prescriptions with remaining refills, limited to one transfer per prescription [10]

For ongoing care, you will need a Nebraska-licensed provider. A telehealth platform with multistate licensing makes this transition straightforward. Bring your most recent lab results (within 6 months) and your current dose to the new provider visit, which eliminates the need to repeat baseline labs.

Timeline: From First Lab Draw to First Dose

Patients frequently ask how long the process takes. A realistic timeline:

• Days 1 to 3: Lab draw at a local Quest or Labcorp site. Results return in 2 to 3 business days for standard panels.
• Days 4 to 5: Telehealth consultation. Some platforms offer same-day or next-day appointments after labs are available.
• Days 5 to 12: Prior authorization (if using insurance). Commercial PA takes 3 to 7 business days. Cash-pay patients skip this step.
• Days 6 to 14: Pharmacy fills and ships. Specialty pharmacy mail-order typically delivers within 3 to 5 business days. Local pickup from a stocking pharmacy can happen same day.

Total: 6 to 14 business days for most patients. Cash-pay patients using a 503A or 503B pharmacy often receive medication within 5 to 7 business days from initial lab draw.